Lv4
740 积分 2025-07-03 加入
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
1个月前
已完结
Prevention of heart failure after acute myocardial infarction
1个月前
已完结
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
1个月前
已关闭
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
1个月前
已关闭
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
1个月前
已关闭
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
1个月前
已关闭
Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
1个月前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
1个月前
已完结
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities
1个月前
已完结
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial
2个月前
已完结
皖公网安备34019202002308
